Ascletis Pharma Inc
Ascletis Pharma's GHG Emissions Data Preview
In 2023, Ascletis Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Ascletis Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | Copy restricted. Please purchase to unlock this data. | 0000000 |
Verified Sources Behind Ascletis Pharma’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Ascletis Pharma’s data sources below and access millions more through our Disclosure Search.
Insights into Ascletis Pharma's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Ascletis Pharma amounted to 3,221.47 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Ascletis Pharma increased by 42.95%, suggesting that the company faced challenges in reducing its emissions from its core operations. a b
Ascletis Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Ascletis Pharma's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Ascletis Pharma were 421.6 metric tons of CO₂ equivalent (tCO₂e). a
Compared to the previous year (2022), Ascletis Pharma's Scope 1 emissions increased by 1,792.28%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a b
What are Ascletis Pharma's Scope 2 emissions?
In 2023, Ascletis Pharma reported Scope 2 greenhouse gas (GHG) emissions of 2,799.87 tCO₂e without specifying the calculation method. a
Has Ascletis Pharma reduced its Scope 2 emissions over time?
Compared to the previous year (2022), Ascletis Pharma's Scope 2 emissions (Unspecified Calculation Method) rose by 25.48% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a b
What methodology does Ascletis Pharma use for Scope 2 reporting?
In 2023, Ascletis Pharma reported its Scope 2 emissions using an unspecified methodology. a
Ascletis Pharma's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Ascletis Pharma’s GHG Emissions Intensity Compared to Industry Peers
In 2023, Ascletis Pharma reported Scope 1 greenhouse gas (GHG) emissions of 421.6 tCO₂e and total revenues of USD 9 millions. This translates into an emissions intensity of 48.5 tCO₂e per millions USD. a
Ascletis Pharma's Scope 1 Emissions Intensity Compared to Peers
How does Ascletis Pharma's GHG emissions intensity compare to its peers?
In 2023, Ascletis Pharma reported a Scope 1 emissions intensity of 48.5 tCO₂e per millions USD. Compared to the peer group median of 8.49 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does Ascletis Pharma rank on GHG emissions intensity within its industry?
In 2023, Ascletis Pharma ranked 22 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places Ascletis Pharma among the least efficient performers, with one of the highest emissions intensities in its sector. a